Videos

In part 4 of this Exclusive Interview, Dr. Jim McDermott discusses patient response to the DURATION-8 study, and the continuation of the study in 2018, in a conversation with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA.

In part 5 of this Exclusive Interview, Dr. Jim McDermott explains DapaCare, the umbrella term that covers AstraZeneca's clinical program with Farxiga (dapagliflozin) in a conversation with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA.

In part 6, the conclusion of this Exclusive Interview, Dr. Jim McDermott explains SGLT2 cardiovascular trials, including the DECLARE trial that will complete in 2018, in a conversation with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA.

In part 7, the conclusion of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about the side effects so far of the new inhibitor drug and watching for reactions.

Dr. Ronald S. Swerdloff graduated with his BS from UCLA/UCB in 1959 and an MDvin 1962 from UCSF. He began his clinical training at the University of Washington, only to be drafted and expected to serve as a medical officer in the Vietnam war. Instead he was assigned to a brilliant physician scientist at the NIH and finally finished his training back at UCLA. Dr. Swerdloff has been a leader in reproductive endocrinology for the last four decades, including pubertal development, male contraception, androgen physiology and modeling, androgen drug development and hormones in aging.

In this Exclusive Interview transcript, Dr. Ronald Swerdloff discusses his work on male hypogonadism and diabetes, low testosterone treatments, and the impact of such treatment on cancer.

In this Exclusive Interview, Dr. Ronald Swerdloff talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about male hypogonadism, low testosterone treatements, and the impact of such treatment on cancer.

In part 1 of this Exclusive Interview, Dr. Ronald Swerdloff explains male hypogonadism in a conversation with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA.

In part 2 of this Exclusive Interview, Dr. Ronald Swerdloff talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about methods to lower testosterone.

In part 3 of this Exclusive Interview, Dr. Ronald Swerdloff talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the affect of added testosterone on pre-existing cancer.